Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/Sales ratio is N/A as of 2026-10-06T18:05:20.887Z.
Calculation as of: 2026-10-06T18:05:20.887Z.
Quote observation: 2026-10-06T18:00:22.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: eb6c183c54b52a3f5be7b88cd35f52a8db6123751fb387d2cb2c86d403628cdc
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2019-08-13.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
N/A
EV/SALES RATIO AVG TTM
N/A
EV/SALES RATIO AVG 3Y
N/A
EV/SALES RATIO AVG 5Y
N/A
EV/SALES RATIO AVG 10Y
N/A
EV/SALES RATIO AVG 15Y
N/A
EV/SALES RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$408.45M
EV/Sales Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$409.37M
EV/Sales Ratio
6.66x
TTM Avg
6.44x
3Y Avg
6.66x
5Y Avg
6.66x
Market Cap
$406.75M
EV/Sales Ratio
N/A
TTM Avg
403.83x
3Y Avg
403.83x
5Y Avg
403.83x
Market Cap
$412.62M
EV/Sales Ratio
0.63x
TTM Avg
0.69x
3Y Avg
1.51x
5Y Avg
2.02x
Market Cap
$412.30M
EV/Sales Ratio
1.56x
TTM Avg
1.64x
3Y Avg
1.28x
5Y Avg
2.81x
Market Cap
$404.94M
EV/Sales Ratio
N/A
TTM Avg
0.91x
3Y Avg
12.05x
5Y Avg
12.05x
Market Cap
$413.34M
EV/Sales Ratio
8.87x
TTM Avg
9.19x
3Y Avg
12.86x
5Y Avg
31.40x
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Rezolute, Inc. (RZLT) | $408.76M | N/A | N/A | N/A | N/A |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $408.45M | N/A | N/A | N/A | N/A |
| Shoulder Innovations, Inc. (SI)vs › | $409.37M | 6.66x | 6.44x | 6.66x | 6.66x |
| Carlsmed, Inc. (CARL)vs › | $407.13M | 6.05x | 3.70x | 3.81x | 3.81x |
| Neurogene Inc. (NGNE)vs › | $406.75M | N/A | 403.83x | 403.83x | 403.83x |
| Myriad Genetics, Inc. (MYGN)vs › | $412.62M | 0.63x | 0.69x | 1.51x | 2.02x |
| Strata Critical Medical, Inc. (SRTA)vs › | $412.30M | 1.56x | 1.64x | 1.28x | 2.81x |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $404.94M | N/A | 0.91x | 12.05x | 12.05x |
| Senseonics Holdings, Inc. (SENS)vs › | $413.34M | 8.87x | 9.19x | 12.86x | 31.40x |
| MapLight Therapeutics, Inc. (MPLT)vs › | $397.20M | N/A | N/A | N/A | N/A |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/SALES RATIO |
|---|---|
| 2019-08-13 | 0.11x |
| 2019-08-06 | 0.01x |
| 2019-08-05 | 0.23x |
| 2019-08-02 | 0.23x |
| 2019-08-01 | 0.70x |
| 2019-07-29 | 0.48x |
| 2019-07-26 | 0.66x |
| 2019-07-25 | 0.78x |
| 2019-07-24 | 0.42x |
| 2019-07-23 | 0.26x |
| 2019-07-22 | 0.23x |
| 2019-07-19 | 0.16x |
| 2019-07-18 | 0.09x |
| 2019-07-17 | 0.09x |
| 2019-07-16 | 0.10x |
| 2019-05-10 | 0.81x |
| 2019-05-09 | 0.89x |
| 2019-05-08 | 0.89x |
| 2019-05-07 | 0.81x |
| 2019-05-06 | 0.81x |
| 2019-05-03 | 0.81x |
| 2019-05-02 | 0.81x |
| 2019-05-01 | 0.81x |
| 2019-04-30 | 0.81x |
| 2019-04-29 | 0.81x |
| 2019-04-26 | 0.81x |
| 2019-04-25 | 0.81x |
| 2019-04-24 | 0.83x |
| 2019-04-23 | 0.84x |
| 2019-04-22 | 0.99x |
| 2019-04-18 | 1.00x |
| 2019-04-17 | 1.03x |
| 2019-04-16 | 0.94x |
| 2019-04-15 | 0.84x |
| 2019-04-12 | 1.37x |
| 2019-04-11 | 1.01x |
| 2019-04-10 | 0.96x |
| 2019-04-09 | 0.96x |
| 2019-04-08 | 0.91x |
| 2019-04-05 | 0.91x |
| 2019-04-04 | 0.84x |
| 2019-04-03 | 0.84x |
| 2019-04-02 | 0.84x |
| 2019-04-01 | 0.84x |
| 2019-03-29 | 0.87x |
| 2019-03-28 | 0.87x |
| 2019-03-27 | 0.87x |
| 2019-03-26 | 0.87x |
| 2019-03-25 | 0.87x |
| 2019-03-22 | 0.96x |
| 2019-03-21 | 0.96x |
| 2019-03-20 | 0.96x |
| 2019-03-19 | 0.96x |
| 2019-03-18 | 0.97x |
| 2019-03-15 | 0.97x |
| 2019-03-14 | 0.97x |
| 2019-03-13 | 0.77x |
| 2019-03-12 | 1.00x |
| 2019-03-11 | 1.00x |
| 2019-03-08 | 1.01x |
| 2019-03-07 | 1.01x |
| 2019-03-06 | 0.87x |
| 2019-03-05 | 1.03x |
| 2019-03-04 | 1.16x |
| 2019-03-01 | 1.19x |
| 2019-02-28 | 1.19x |
| 2019-02-27 | 1.43x |
| 2019-02-26 | 1.19x |
| 2019-02-25 | 1.19x |
| 2019-02-22 | 1.00x |
| 2019-02-21 | 1.00x |
| 2019-02-20 | 1.00x |
| 2019-02-19 | 0.87x |
| 2019-02-15 | 0.84x |
| 2019-02-14 | 0.79x |
| 2019-02-13 | 0.83x |
| 2019-02-12 | 0.95x |
| 2019-02-11 | 0.95x |
| 2019-02-08 | 0.95x |
| 2019-02-07 | 0.95x |
| 2019-02-06 | 0.95x |
| 2019-02-05 | 0.95x |
| 2019-02-04 | 0.82x |
| 2019-02-01 | 0.95x |
| 2019-01-31 | 0.95x |
| 2019-01-30 | 0.95x |
| 2019-01-29 | 0.95x |
| 2019-01-28 | 0.95x |
| 2019-01-25 | 0.95x |
| 2019-01-24 | 0.95x |
| 2019-01-23 | 0.95x |
| 2019-01-22 | 0.95x |
| 2019-01-18 | 0.95x |
| 2019-01-17 | 0.95x |
| 2019-01-16 | 1.04x |
| 2019-01-15 | 1.04x |
| 2019-01-14 | 1.04x |
| 2019-01-11 | 0.95x |
| 2019-01-10 | 0.95x |
| 2019-01-09 | 1.04x |
| 2019-01-08 | 1.16x |
| 2019-01-07 | 1.30x |
| 2019-01-04 | 0.51x |
| 2019-01-03 | 0.48x |
| 2019-01-02 | 0.48x |
